| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 7,590 | $30 | $250.4K |
| J9312 | Injection, rituximab, 10 mg | 2,250 | $60 | $144K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 4,910 | $20 | $108.1K |
| J3262 | Injection, tocilizumab, 1 mg | 19,460 | $10 | $97.3K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 21,200 | $1 | $84.8K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 6,470 | $10 | $71.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 330 | $90 | $29K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 300 | $90 | $26.2K |
| J0897 | Injection, denosumab, 1 mg | 1,380 | $20 | $24.8K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 310 | $60 | $17.4K |